Severe Fungal Infections
Severe fungal infections go beyond superficial skin conditions. They penetrate deep tissue, enter the bloodstream, or spread to internal organs, making them a medical emergency in many cases. Immunocompromised patients, those recovering from major surgery, and people living with uncontrolled diabetes are at higher risk, and tropical climates can extend the range of certain fungal species year-round.
Key points
- These infections rarely affect healthy people but become far more dangerous when the immune system is weakened by illness, chemotherapy or long-term steroid use.
- Ketoconazole is one antifungal used for this purpose; it works by blocking the fungus’s ability to build ergosterol, a component of its cell membrane.
- In intensive care settings, hospital-acquired Candida or Aspergillus infections are a recognised risk to watch for.
Who faces the highest risk
Fungi that cause severe disease rarely affect healthy people. The danger rises sharply when the immune system is weakened, whether by HIV, cancer chemotherapy, long-term corticosteroids, or organ transplant drugs. Hospital-acquired infections involving species such as Candida or Aspergillus are a concern in intensive care units.
Antifungal treatment
Systemic antifungal medicines work by disrupting the fungal cell membrane or blocking cell-wall synthesis. Ketoconazole is one such agent from the antifungals class; it inhibits fungal ergosterol synthesis and has been used for a range of deep dermatophyte and yeast infections. Treatment duration varies widely depending on which fungus is involved, the organs affected, and how well the person’s immune system responds.
Seek urgent medical evaluation if you develop persistent high fever, breathing difficulties, or neurological changes alongside a suspected fungal infection.